Main Menu

Dr. Vathyam returned to the OTT in 2007, having been an intern with OTT earlier in her career. Previously, at the USPTO she examined inventions relating to electrochemistry including biosensors, electrophoresis and microfluidics. For several years, she was the Director of Research and Development at a biotech company where she negotiated contracts and licenses, while developing medical diagnostics and therapeutics. She earned her Ph.D. from The Johns Hopkins University in Biochemistry, where she performed NMR studies on iron containing superoxide dismutase. She received her M.Sc.

Ms. Rucker has over 20 years of experience in intellectual property related matters. Ms. Rucker has worked at the NIH OTT since November of 1991, first as a Patent Advisor and then as a Technology Licensing Specialist (TLS), assuming her position as Senior TLS in September 2005. Prior to joining the Office of Technology Transfer was an examiner at the USPTO for 5 ½ years and was awarded partial signatory authority. Ms. Rucker received her J.D. from the Columbus School of Law at the Catholic University of America (May 1992). Ms Rucker is a member of the Maryland Bar (Dec. 1992).

Dr. Lambertson joined the OTT in 2005. Prior to joining the NIH, Dr. Lambertson was a patent examiner with the US Patent and Trademark Office. Dr. Lambertson received his Ph.D. in Biochemistry and Molecular Biology from The University of Medicine and Dentistry of New Jersey, and his BS in Biochemistry from Rutgers University, where he was a George H. Cook Scholar.

Jaime is a USPTO alum where she worked in Art Unit 1634 evaluating nucleic acid hybridization-related patent applications. Prior to working at the PTO, she worked at a small systems biology startup company in Cambridge, MA. Jaime obtained her master’s degree from the University of Heidelberg in Heidelberg, Germany and her bachelor’s degree from the George Washington University in Washington, DC.

Dr. Chang joined OTT in May 2008. Prior to joining OTT, he was a technology transfer specialist fellow at the National Cancer Institute (NCI) Technology Transfer Center assisting NCI scientists with agreements for the transfer of materials and collaborations with public and private entities. This followed several years as a postdoctoral fellow at NCI Frederick where he studied and published several papers on retroviral vectors and replication. Dr. Chang received his Ph.D.